Sign inJoin waitlistJoin the waitlist

James Mohler

Associate Director and Senior Vice President · University of Chicago Medical Center

Credentials: · ·

History

Inter-Institutional Academics Division · University at Buffalo School of Medicine
Present
University at Buffalo School of Medicine
Present
Emeritus – Department of Urology · ROSWELL PARK CANCER INSTITUTE
Present

Urology
University of Kentucky Hospital
1983–1988
Internal Medicine
Duke University Hospital
1980–1983
Medical College of Georgia
1976–1980

Research

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · First of 33 authors · 1,050 citations
NCCN clinical practice guidelines in oncology: prostate cancer
Journal of the National Comprehensive Cancer Network · 2010 · First of 25 authors · 733 citations
Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder…
Journal of the National Cancer Institute · 1993 · 630 citations

Khurshid Guru
33 papers · 10 as a fellow
Hyung Kim
17 papers
Alan Partin
16 papers · 9 as a resident
Gissou Azabdaftari
15 papers
Susan Maygarden
14 papers
Eric Small
12 papers
JP
John Parsons
12 papers
JE
James Eastham
11 papers
MK
Mark Kawachi
11 papers
RB
Robert Bahnson
11 papers
JE
Jonathan Epstein
10 papers
PG
Paul Godley
10 papers

Grants

Roswell Park Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $441.5K · Roswell Park Cancer Institute Corp
1997–2024
A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer
National Cancer Institute · R21
Contact PI · $421.8K · Roswell Park Cancer Institute Corp
2016–2020
Prostate Cancer: Transition to Androgen - Independence (CA77739)
National Cancer Institute · P01
Contact PI · $14.6M · Univ of North Carolina Chapel Hill
1998–2017
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $676.5K · Univ of North Carolina Chapel Hill
1998–2002

Clinical trials

Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Principal investigator · Completed
Roswell Park Cancer Institute
2009–2020
Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer
Principal investigator · Withdrawn · Phase 2
Roswell Park Cancer Institute
2008
Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Principal investigator · Completed · Phase 2
Roswell Park Cancer Institute
2008–2012
Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
Principal investigator · Completed · Phase 2
Roswell Park Cancer Institute
2004–2013